Introduction: Studies suggest that weight loss induced by bariatric surgery and the
remission of some comorbidities may be related to changes in the microbiota
profile of individuals undergoing this procedure. In addition, there is
evidence that manipulation of the intestinal microbiota may prove to be a
therapeutic approach against obesity and metabolic diseases. Objective: To verify the changes that occur in the intestinal microbiota of patients
undergoing bariatric surgery, and the impact of the usage of probiotics in
this population. Methods: Articles published between 2007 and 2017 were searched in Medline, Lilacs and
Pubmed with the headings: bariatric surgery, microbiota, microbiome and
probiotics, in Portuguese, English and Spanish. Of the 166 articles found,
only those studies in adults subjected to either Roux-en-Y gastric bypass or
sleeve vertical gastrectomy published in original articles were enrolled. In
the end, five studies on the change of intestinal microbiota composition,
four on the indirect effects of those changes and three on the probiotics
administration on this population were enrolled and characterized. Conclusion: Bariatric surgery provides changes in intestinal microbiota, with a relative
increase of the Bacteroidetes and Proteobacteria phyla and reduction of
Firmicutes. This is possibly due to changes in the gastro-intestinal flux,
coupled with a reduction in acidity, in addition to changes in eating
habits. The usage of probiotics seems to reduce the gastro-intestinal
symptoms in the post-surgery, favor the increase of vitamin B12 synthesis,
as well as potentiate weight loss.